Mawer Investment Management
CRL icon

Mawer Investment Management’s Charles River Laboratories CRL Stock Holding History

Mawer Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,912
Closed -$7.81M – 111
2025
Q1 		$7.81M Buy
51,912
+5,283
+11% +$886K 0.04% 97
2024
Q4 		$8.61M Buy
46,629
+5,769
+14% +$1.11M 0.04% 93
2024
Q3 		$8.05M Sell
40,860
-32,693
-44% -$6.79M 0.04% 97
2024
Q2 		$15.2M Buy
73,553
+27,954
+61% +$6.33M 0.07% 79
2024
Q1 		$12.4M Buy
45,599
+19,574
+75% +$4.67M 0.06% 78
2023
Q4 		$6.15M Buy
26,025
+7,014
+37% +$1.38M 0.03% 78
2023
Q3 		$3.73M Buy
19,011
+1,744
+10% +$358K 0.02% 83
2023
Q2 		$3.63M Buy
17,267
+1,434
+9% +$285K 0.02% 81
2023
Q1 		$3.2M Buy
15,833
+500
+3% +$113K 0.02% 84
2022
Q4 		$3.34M Buy
15,333
+2,766
+22% +$604K 0.02% 85
2022
Q3 		$2.47M Buy
12,567
+3,644
+41% +$787K 0.02% 81
2022
Q2 		$1.91M Buy
8,923
+2,951
+49% +$721K 0.01% 81
2022
Q1 		$1.7M Buy
5,972
+3,040
+104% +$937K 0.01% 85
2021
Q4 		$1.1M Buy
2,932
+1,919
+189% +$746K 0.01% 96
2021
Q3 		$418K Buy
+1,013
New +$421K ﹤0.01% 98

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Mawer Investment Management's CRL Position: Q2 2025 in Review

Mawer Investment Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 51,912 shares — an estimated $7.81M sold.

Mawer Investment Management first reported a position in CRL in Q3 2021 and held it in 15 quarters. The position peaked at $15.2M in Q2 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Mawer Investment Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Mawer Investment Management sold 51,912 Charles River Laboratories shares in Q2 2025, an estimated $7.81M.
  • Mawer Investment Management first reported a position in Charles River Laboratories in Q3 2021 and held it in 15 quarters.
  • Mawer Investment Management's Charles River Laboratories position peaked at $15.2M in Q2 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Mawer Investment Management's 13F filing for Q2 2025, filed 7 Aug 2025.